Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders

被引:21
作者
Akinbami, Lara J. [1 ,2 ]
Biggerstaff, Brad J. [3 ]
Chan, Philip A. [4 ]
McGibbon, Emily [5 ]
Pathela, Preeti [5 ]
Petersen, Lyle R. [3 ]
机构
[1] Natl Ctr Hlth Stat, Ctr Dis Control, Hyattsville, MD USA
[2] US PHS, Rockville, MD USA
[3] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA
[4] Rhode Isl Dept Hlth, Providence, RI 02908 USA
[5] New York City Dept Hlth & Mental Hyg, Queens, NY USA
关键词
SARS-CoV-2; reinfection; antibody; healthcare personnel; first responders; PUBLIC SAFETY PERSONNEL; WORKERS; USA;
D O I
10.1093/cid/ciab952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 reinfection was uncommon among first responders and healthcare personnel before widespread variant circulation. Seropositivity was protective against reinfection. Exposure to household member(s) with coronavirus disease 2019 prior to serology testing was protective. Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus testing among first responders and healthcare personnel who participated in a May 2020-August 2020 serosurvey that assessed spike protein antibodies provided an opportunity to assess reinfection. Methods Serology survey data were merged with virus testing results from Rhode Island (1 March 2020-17 February 2021) and New York City (10 March 2020-14 December 2020). Participants with a positive virus test >= 14 days before their serology test were included. Reinfection was defined as a second positive SARS-CoV-2 test >= 90 days after the first positive test. The association between serostatus and reinfection was assessed with a proportional hazards model. Results Among 1572 previously infected persons, 40 (2.5%) were reinfected. Reinfection differed by serostatus: 8.4% among seronegative vs 1.9% among seropositive participants (P < .0001). Most reinfections occurred among Rhode Island nursing home and corrections personnel (n = 30) who were most frequently tested (mean 30.3 tests vs 4.6 for other Rhode Island and 2.3 for New York City participants). The adjusted hazard ratio (aHR) for reinfection in seropositive vs seronegative persons was 0.41 (95% confidence interval [CI], .20-.81). Exposure to a household member with coronavirus disease 2019 (COVID-19) before the serosurvey was also protective (aHR, 0.34; 95% CI, .13-.89). Conclusions Reinfections were uncommon among previously infected persons over a 9-month period that preceded widespread variant circulation. Seropositivity decreased reinfection risk. Lower reinfection risk associated with exposure to a household member with COVID-19 may reflect subsequently reduced household transmission.
引用
收藏
页码:E201 / E207
页数:7
相关论文
共 31 条
[1]   SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Coyle, Peter ;
Malek, Joel A. ;
Ahmed, Ayeda A. ;
Mohamoud, Yasmin A. ;
Younuskunju, Shameem ;
Ayoub, Houssein H. ;
Al Kanaani, Zaina ;
Al Kuwari, Einas ;
Butt, Adeel A. ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar Hassan ;
Latif, Ali Nizar ;
Shaik, Riyazuddin Mohammad ;
Rahim, Hanan F. Abdul ;
Nasrallah, Gheyath K. ;
Yassine, Hadi M. ;
Al Kuwari, Mohamed Ghaith ;
Al Romaihi, Hamad Eid ;
Al-Thani, Mohamed H. ;
Al Khal, Abdullatif ;
Bertollini, Roberto .
ECLINICALMEDICINE, 2021, 35
[2]   Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020 [J].
Akinbami, Lara J. ;
Chan, Philip A. ;
Vuong, Nga ;
Sami, Samira ;
Lewis, Dawn ;
Sheridan, Philip E. ;
Lukacs, Susan L. ;
Mackey, Lisa ;
Grohskopf, Lisa A. ;
Patel, Anita ;
Petersen, Lyle R. .
EMERGING INFECTIOUS DISEASES, 2021, 27 (03) :823-834
[3]   SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel Detroit Metropolitan Area, Michigan, USA, May-June 2020 [J].
Akinbami, Lara J. ;
Vuong, Nga ;
Petersen, Lyle R. ;
Sami, Samira ;
Patel, Anita ;
Lukacs, Susan L. ;
Mackey, Lisa ;
Grohskopf, Lisa A. ;
Shehu, Amy ;
Atas, Jenny .
EMERGING INFECTIOUS DISEASES, 2020, 26 (12) :2863-2871
[4]  
Barry Mazin, 2021, Med Sci (Basel), V9, DOI 10.3390/medsci9030049
[5]  
Centers for Disease Control and Prevention, TEST INF
[6]  
Centers for Disease Control and Prevention, SER TEST EV REP VITR
[7]  
Cohen Cheryl, 2021, medRxiv, DOI 10.1101/2021.07.20.21260855
[8]  
Council of State and Territorial Epidemiologists, 21 ID 01 UPD STAND S
[9]  
Epidemiologists CoSaT, COR DIS 2019 COVID 1
[10]  
Frascella B., 2021, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1402, DOI 10.1093/CID/CIAA1402]